Nonalcoholic Fatty Liver Disease

被引：157
作者：
Wang, Xiao Jing [1 ]
Malhi, Harmeet [1 ]
机构：
[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2018年 / 169卷 / 09期
关键词：
HEPATIC STEATOSIS; UNITED-STATES; WEIGHT-LOSS; VITAMIN-E; STEATOHEPATITIS; CIRRHOSIS; FIBROSIS; DIAGNOSIS; TRANSPLANTATION; UTILITY;
D O I：
10.7326/AITC201811060
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：ITC65 / ITC80
页数：16
相关论文
共 49 条
[1]   The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD [J].
Angulo, Paul ;
Hui, Jason M. ;
Marchesini, Giulio ;
Bugianesi, Ellisabetta ;
George, Jacob ;
Farrell, Geoffrey C. ;
Enders, Felicity ;
Saksena, Sushma ;
Burt, Alastair D. ;
Bida, John P. ;
Lindor, Keith ;
Sanderson, Schuyler O. ;
Lenzi, Marco ;
Adams, Leon A. ;
Kench, James ;
Therneau, Terry M. ;
Day, Christopher P. .
HEPATOLOGY, 2007, 45 (04) :846-854
[2]   Long-Term Mortality in Nonalcoholic Fatty Liver Disease: Is Liver Histology of Any Prognostic Significance? [J].
Angulo, Paul .
HEPATOLOGY, 2010, 51 (02) :373-375
[3]   Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction [J].
Browning, Jeffrey D. ;
Baker, Jonathan A. ;
Rogers, Thomas ;
Davis, Jeannie ;
Satapati, Santhosh ;
Burgess, Shawn C. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2011, 93 (05) :1048-1052
[4]   Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials [J].
Caussy, Cyrielle ;
Reeder, Scott B. ;
Sirlin, Claude B. ;
Loomba, Rohit .
HEPATOLOGY, 2018, 68 (02) :763-772
[5]   Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis [J].
Caussy, Cyrielle ;
Soni, Meera ;
Cui, Jeffrey ;
Bettencourt, Ricki ;
Schork, Nicholas ;
Chen, Chi-Hua ;
Al Ikhwan, Mahdi ;
Bassirian, Shirin ;
Cepin, Sandra ;
Gonzalez, Monica P. ;
Mendler, Michel ;
Kono, Yuko ;
Vodkin, Irine ;
Mekeel, Kristin ;
Haldorson, Jeffrey ;
Hemming, Alan ;
Andrews, Barbara ;
Salotti, Joanie ;
Richards, Lisa ;
Brenner, David A. ;
Sirlin, Claude B. ;
Loomba, Rohit .
JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (07) :2697-2704
[6]   The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases [J].
Chalasani, Naga ;
Younossi, Zobair ;
Lavine, Joel E. ;
Charlton, Michael ;
Cusi, Kenneth ;
Rinella, Mary ;
Harrison, Stephen A. ;
Brunt, Elizabeth M. ;
Sanyal, Arun J. .
HEPATOLOGY, 2018, 67 (01) :328-357
[7]   Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design [J].
Chalasani, Naga P. ;
Sanyal, Arun J. ;
Kowdley, Kris V. ;
Robuck, Patricia R. ;
Hoofnagle, Jay ;
Kleiner, David E. ;
Uenalp, Aynur ;
Tonascia, James .
CONTEMPORARY CLINICAL TRIALS, 2009, 30 (01) :88-96
[8]   Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States [J].
Charlton, Michael R. ;
Burns, Justin M. ;
Pedersen, Rachel A. ;
Watt, Kymberly D. ;
Heimbach, Julie K. ;
Dierkhising, Ross A. .
GASTROENTEROLOGY, 2011, 141 (04) :1249-1253
[9]   Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation [J].
Crossan, Catriona ;
Tsochatzis, Emmanuel A. ;
Longworth, Louise ;
Gurusamy, Kurinchi ;
Davidson, Brian ;
Rodriguez-Peralvarez, Manuel ;
Mantzoukis, Konstantinos ;
O'Brien, Julia ;
Thalassinos, Evangelos ;
Papastergiou, Vassilios ;
Burroughs, Andrew .
HEALTH TECHNOLOGY ASSESSMENT, 2015, 19 (09) :1-+
[10]   Controlled attenuation parameter (CAP) for the diagnosis of steatosis: A prospective study of 5323 examinations [J].
de Ledinghen, Victor ;
Vergniol, Julien ;
Capdepont, Maylis ;
Chermak, Faiza ;
Hiriart, Jean-Baptiste ;
Cassinotto, Christophe ;
Merrouche, Wassil ;
Foucher, Juliette ;
Brigitte, Le Bail .
JOURNAL OF HEPATOLOGY, 2014, 60 (05) :1026-1031
12345